3-Cyclopropylthiomorpholine 1,1-dioxide hydrochloride, 1g

Ethyl 7-(oxiran-2-yl)heptanoate, 98%, 50mg

3,4-Difluoro-2-((phenylthio)methyl)benzoic acid, 98%, 5g

6-Bromoimidazo[1,2-a]pyridine-3-carbonitrile, 98%, 5g

Ethyl (S)-2-amino-3,3-dimethylbutanoate, 95%, 25g

2-Chloro-6-fluoro-3-methylbenzylamine, 1g

3-(2-FLUORO-4-(TRIFLUOROMETHYL)PHENYL)-1H-PYRROLE-2,5-DIONE, 95.0%, 250mg

tert-Butyl 6-(benzyloxy)-1H-indole-1-carboxylate, 95.0%, 1g

Methyl[1-(naphthalen-1-yl)ethyl]amine, 95%, 1g

GC capillary column ROTI®Cap-1701, 30 m, 0.25 mm, 0.25 µm, 1 Piece(s)

2'-Bromoacetophenone>98.0%(GC)25g

2,3-Dihydro-1-benzofuran-2-carboxylic acid, 97.0%, 5g

1-(2,6-Dichloropyridin-4-yl)ethanone, 95.0%, 250mg